Genopliv ApS: Financial statements 2025
CVR: 43711172
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Genopliv ApS (CVR 43711172) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,031,847 and a net result of DKK 117,485 compared with DKK 170,895 the year before. That is a decrease of 15% compared with the year before. Equity in the 2025 report amounted to DKK 725,199. The solvency ratio was 49.8%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,031,847
- Profit/Loss
- DKK 117,485
- Equity
- DKK 725,199
- Total Assets
- DKK 1,455,585
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1M | 117K | 725K | 1 |
| 2024 | - | 1.2M | 171K | 663K | 1 |
| 2023 | - | 1.3M | 492K | 532K | 1 |
Official annual report
How creditworthy is Genopliv ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Genopliv ApS has published its annual report for 2024. Gross profit came to DKK 1,214,424, and the net result was DKK 170,895.
About Genopliv ApS
Genopliv ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 2022. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Kim Janos Pedersen. The company is owned by Kim Janos Pedersen. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 1,031,847 and a net result of DKK 117,485 compared with DKK 170,895 the year before. Equity in the 2025 report amounted to DKK 725,199.